IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
IMMUTEP Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Oct 24, 2025
$3.17−0.03 (-0.94%)
Close on Oct 19, 2026
Share price
−$38.23 (−92.34%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
IMMUTEP Ltd grew revenue 31.8% to A$10.33M over fiscal 2025. Free cash flow was -A$62.10M.
Revenue
A$10.33M
+31.8% vs. a year earlier
Free cash flow
-A$62.10M
FY2025
EPS, diluted
-0.04 AUD
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- A$10.33M
- Net income
- -A$61.43M
- EPS, diluted
- -0.04 AUD
- Free cash flow
- -A$62.10M
Valuation needs the share price. It fills in once daily prices are connected and converted from AUD.
Eleven years at a glance
Fiscal years 2015 to 2025, AUD
Revenue
A$10.33M+31.8% YoY
Net income
-A$61.43M
EPS, diluted
-0.04 AUD
Free cash flow
-A$62.10M
Reported period